Regeneron's strategy focuses on a broad pipeline across six therapeutic areas, with significant near-term data readouts ...

Novartis has significantly strengthened its neuroscience pipeline over recent years, topped by the $12bn acquisition of ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

ACCESS-AD launches at a pivotal time for Alzheimer’s disease management in Europe. Recent approvals of antibody-based disease-modifying therapies (DMTs) have expanded the treatment landscape, but ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

There are many teas you can drink when you have a cold, but the best options help alleviate your symptoms. Here are some top choices to try.

According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...